Skip to main content
SpringerLink
Log in
Book cover

Tumors of the Central Nervous System, Volume 2 pp 335–347Cite as

Glioblastoma Multiforme: Use of Adenoviral Vectors

  • Chapter
  • First Online:

  • 1767 Accesses

Part of the book series: Tumors of the Central Nervous System ((TCNS,volume 2))

Abstract

Glioblastoma multiforme is a tumour of the brain with extremely poor prognosis. It constitutes approximately 60–70% of all primary brain tumours with a mean survival of 14.6 months after diagnosis. Current standard therapy includes surgical resection followed by adjuvant radiotherapy and/or chemotherapy. With the introduction of gene therapy a new therapeutic area has been opened and numerous approaches are currently been studied in pre-clinical as well as in clinical settings for the treatment of brain tumours. These include pro-drug activation/suicide gene therapy, anti-angiogenic gene therapy, oncolytic virotherapy, immune modulation and many other strategies, which will be discussed in this review. The use of suicide gene therapy has been probably one of the most studied therapeutic approaches and will be also discussed in this review in more detail.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Chiocca EA, Abbed KM, Tatter S, Louis DN, Hochberg FH, Barker F, Kracher J, Grossman SA, Fisher JD, Carson K, Rosenblum M, Mikkelsen T, Olson J, Markert J, Rosenfeld S, Nabors LB, Brem S, Phuphanich S, Freeman S, Kaplan R, Zwiebel J (2004) A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Mol Ther 10:958–966

    Article  PubMed  CAS  Google Scholar 

  • Ciafre SA, Niola F, Wannenes F, Farace MG (2004) An anti-VEGF ribozyme embedded within the adenoviral VAI sequence inhibits glioblastoma cell angiogenic potential in vitro. J Vasc Res 41:220–228

    Article  PubMed  CAS  Google Scholar 

  • Furukawa K, Kumon Y, Harada H, Kohno S, Nagato S, Teraoka M, Fujiwara S, Nakagawa K, Hamada K, Ohnishi T (2006) PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules. Int J Oncol 29:73–81

    PubMed  CAS  Google Scholar 

  • Ghulam Muhammad AK, Candolfi M, King GD, Yagiz K, Foulad D, Mineharu Y, Kroeger KM, Treuer KA, Nichols WS, Sanderson NS, Yang J, Khayznikov M, Van Rooijen N, Lowenstein PR, Castro MG (2009) Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression. Clin Cancer Res 15:6113–6127

    Article  PubMed  CAS  Google Scholar 

  • Gondi CS, Lakka SS, Yanamandra N, Siddique K, Dinh DH, Olivero WC, Gujrati M, Rao JS (2003) Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene 22:5967–5975

    Article  PubMed  CAS  Google Scholar 

  • Gupta V, Wang W, Sosnowski BA, Hofman FM, Chen TC (2006) Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells. Neurosurg Focus 20:E26

    Article  PubMed  Google Scholar 

  • Hamed HA, Yacoub A, Park MA, Eulitt PJ, Dash R, Sarkar D, Dmitriev IP, Lesniak MS, Shah K, Grant S, Curiel DT, Fisher PB, Dent P (2010) Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma. Mol Ther 18(6):1130–1142

    Article  PubMed  CAS  Google Scholar 

  • Hong X, Miller C, Savant-Bhonsale S, Kalkanis SN (2009) Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model. Neurosurgery 64:1139–1146

    Article  PubMed  Google Scholar 

  • Immonen A, Vapalahti M, Tyynela K, Hurskainen H, Sandmair A, Vanninen R, Langford G, Murray N, Yla-Herttuala S (2004) AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 10:967–972

    Article  PubMed  CAS  Google Scholar 

  • Jadhav U, Chigurupati S, Lakka SS, Mohanam S (2004) Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 25:1407–1414

    PubMed  CAS  Google Scholar 

  • Jeong M, Kwon YS, Park SH, Kim CY, Jeun SS, Song KW, Ko Y, Robbins PD, Billiar TR, Kim BM, Seol DW (2009) Possible novel therapy for malignant gliomas with secretable trimeric TRAIL. PLoS One 4:e4545

    Article  PubMed  Google Scholar 

  • Kang YA, Shin HC, Yoo JY, Kim JH, Kim JS, Yun CO (2008) Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus. Mol Ther 16:1033–1040

    Article  PubMed  CAS  Google Scholar 

  • Kang X, Xiao X, Harata M, Bai Y, Nakazaki Y, Soda Y, Kurita R, Tanaka T, Komine F, Izawa K, Kunisaki R, Setoyama M, Nishimori H, Natsume A, Sunamura M, Lozonshi L, Saitoh I, Tokino T, Asano S, Nakamura Y, Tani K (2006) Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas. Cancer Gene Ther 13:385–392

    Article  PubMed  CAS  Google Scholar 

  • Kargiotis O, Chetty C, Gondi CS, Tsung AJ, Dinh DH, Gujrati M, Lakka SS, Kyritsis AP, Rao JS (2008) Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene 27:4830–4840

    Article  PubMed  CAS  Google Scholar 

  • Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP, Kim MH, Kim M, Kim TH, Robbins PD, Billiar TR, Seol DW (2006) Cancer gene therapy using a novel secretable trimeric TRAIL. Gene Ther 13:330–338

    Article  PubMed  CAS  Google Scholar 

  • King GD, Muhammad AK, Curtin JF, Barcia C, Puntel M, Liu C, Honig SB, Candolfi M, Mondkar S, Lowenstein PR, Castro MG (2008) Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model. Neuro Oncol 10:19–31

    Article  PubMed  CAS  Google Scholar 

  • Kohn DB, Candotti F (2009) Gene therapy fulfilling its promise. N Engl J Med 360:518–521

    Article  PubMed  CAS  Google Scholar 

  • Lakka SS, Gondi CS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Rao JS (2003) Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth. Cancer Res 63:2454–2461

    PubMed  CAS  Google Scholar 

  • Lamfers ML, Gianni D, Tung CH, Idema S, Schagen FH, Carette JE, Quax PH, Van Beusechem VW, Vandertop WP, Dirven CM, Chiocca EA, Gerritsen WR (2005) Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma. Cancer Res 65:9398–9405

    Article  PubMed  CAS  Google Scholar 

  • Lu W, Zhou X, Hong B, Liu J, Yue Z (2004) Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP-2 and PTEN gene. Cancer Lett 214:205–213

    Article  PubMed  CAS  Google Scholar 

  • McKnight SL (1980) The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res 8:5949–5964

    Article  PubMed  CAS  Google Scholar 

  • Nalabothula N, Lakka SS, Dinh DH, Gujrati M, Olivero WC, Rao JS (2007) Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and induces glioma cell death. Int J Oncol 30:669–678

    PubMed  CAS  Google Scholar 

  • Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479–489

    PubMed  CAS  Google Scholar 

  • Pan D, Wei X, Liu M, Feng S, Tian X, Feng X, Zhang X 2009. Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells. Neurol Res 32(5):502–509

    Article  PubMed  Google Scholar 

  • Rainov NG (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11:2389–2401

    Article  PubMed  CAS  Google Scholar 

  • Sandmair AM, Loimas S, Puranen P, Immonen A, Kossila M, Puranen M, Hurskainen H, Tyynela K, Turunen M, Vanninen R, Lehtolainen P, Paljarvi L, Johansson R, Vapalahti M, Yla-Herttuala S (2000) Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. Hum Gene Ther 11:2197–2205

    Article  PubMed  CAS  Google Scholar 

  • Stratmann A, Machein MR, Plate KH (1997) Anti-angiogenic gene therapy of malignant glioma. Acta Neurochir Suppl 68:105–110

    PubMed  CAS  Google Scholar 

  • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups and National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466

    Article  PubMed  CAS  Google Scholar 

  • Wirth T, Hedman M, Makinen K, Manninen H, Immonen A, Vapalahti M, Yla-Herttuala S (2006) Safety profile of plasmid/liposomes and virus vectors in clinical gene therapy. Curr Drug Saf 1:253–257

    Article  PubMed  CAS  Google Scholar 

  • Yamini B, Yu X, Pytel P, Galanopoulos N, Rawlani V, Veerapong J, Bickenbach K, Weichselbaum RR (2007) Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy. Clin Cancer Res 13:6217–6223

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute, University of Kuopio, FI-70211, Kuopio, Finland

    Thomas Wirth, Haritha Samaranayake & Seppo Ylä-Herttuala

Authors
  1. Thomas Wirth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haritha Samaranayake
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seppo Ylä-Herttuala
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Wirth .

Editor information

Editors and Affiliations

  1. , Kean University, Room 213, Library building, Morris Avenue 1000, Union, 07083, New Jersey, USA

    M.A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Wirth, T., Samaranayake, H., Ylä-Herttuala, S. (2011). Glioblastoma Multiforme: Use of Adenoviral Vectors. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 2. Tumors of the Central Nervous System, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0618-7_33

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-0618-7_33

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-0617-0

  • Online ISBN: 978-94-007-0618-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation